Updated on 2025/04/05

写真a

 
UENO Harushi
 
Organization
Nagoya University Hospital Thoracic Surgery Assistant professor of hospital
Title
Assistant professor of hospital

Degree 1

  1. Medical Doctor ( 2007.3   University of Yamanashi ) 

 

Papers 49

  1. Impact of Postoperative Therapy on Survival Outcomes in Non-small Cell Lung Cancer Patients With Microscopic Residual Disease Open Access

    Watanabe, H; Nakamura, S; Imamura, Y; Okado, S; Nomata, Y; Kawasumi, Y; Kadomatsu, Y; Ueno, H; Kato, T; Mizuno, T; Chen, TF

    ANTICANCER RESEARCH   Vol. 45 ( 3 ) page: 1193 - 1204   2025.3

     More details

    Language:English   Publisher:Anticancer research  

    BACKGROUND/AIM: The aim of the study was to describe the specific characteristics of patients with microscopic residual disease (R1) after surgical resection for non-small cell lung cancer and to evaluate the effect of postoperative therapy in R1 patients. PATIENTS AND METHODS: We retrospectively reviewed the clinical data of 3,296 patients. Enrolled R1 patients were divided into two groups: those who received postoperative therapy (PT) and those who did not receive postoperative therapy (NPT). RESULTS: A total of 52 R1 patients were enrolled. Of those, 27 (51.9%) underwent extended resections in addition to the standard surgery, 37 patients were assigned to the PT group and 15 to the NPT group. The PT group exhibited significantly longer overall survival (OS) than the NPT group (p<0.01, 5-year OS rate: 62.7% vs. 17.9%). There was no difference in progression-free survival (PFS) between the two groups (p=0.34, 5-year PFS rate: 38.7% vs. 22.2%). Age (<70 years old) and postoperative therapy positively impacted OS (p=0.03, and p=0.01, respectively). CONCLUSION: R1 resection after surgical resection for non-small cell lung cancer was more likely to occur in the patients receiving extended surgical resection. The PT group demonstrated a significantly better prognosis than the NPT group.

    DOI: 10.21873/anticanres.17506

    Open Access

    Web of Science

    Scopus

    PubMed

  2. Lobectomy for primary lung cancer: a comparison of perioperative and postoperative outcomes between robot-assisted thoracic surgery and video-assisted thoracic surgery Open Access

    Ueno, H; Imamura, Y; Okado, S; Nomata, Y; Watanabe, H; Kawasumi, Y; Nakanishi, K; Kadomatsu, Y; Kato, T; Nakamura, S; Mizuno, T; Chen-Yoshikawa, TF

    SURGERY TODAY     2025.2

     More details

    Language:English   Publisher:Surgery Today  

    Purpose: This study compared the peri- and postoperative outcomes of robot-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS) lobectomy for primary lung cancer. Methods: This retrospective cohort study included patients who underwent RATS or VATS at Nagoya University Hospital between April 2018 and March 2022. Propensity score matching was used to balance patient characteristics between the two groups. The following long-term outcomes were assessed: the 3-year overall survival (OS), causes of death, 3-year disease-free survival (DFS), and recurrence patterns. Various peri- and postoperative outcomes were examined as short-term outcomes. Results: After propensity score-matching, 137 patients were included in each group. RATS was associated with a longer operative time (median 180 vs. 144 min, p < 0.001), less blood loss (median 5 vs. 12 ml, p = 0.005), and a lower rate of conversion to open thoracotomy (1 [0.7%] vs. 10 [7.4%], p = 0.010) than VATS. The 3-year OS and DFS were comparable between the groups. Conclusion: In lobectomy for lung cancer, RATS demonstrated long-term outcomes that were comparable to those of VATS. Although RATS has a longer operative time, it is associated with less blood loss and a lower conversion rate to open thoracotomy than VATS, suggesting that it is a beneficial surgical approach for patients.

    DOI: 10.1007/s00595-025-03000-6

    Open Access

    Web of Science

    Scopus

    PubMed

  3. Accuracy of lung structure constructed by three-dimensional image analysis with non-enhanced computed tomography Open Access

    Noritake, O; Okado, S; Kadomatsu, Y; Ueno, H; Kato, T; Nakamura, S; Mizuno, T; Chen-Yoshikawa, TF

    JOURNAL OF THORACIC DISEASE   Vol. 17 ( 2 ) page: 816 - 823   2025.2

     More details

    Language:English   Publisher:Journal of Thoracic Disease  

    Background: There are few papers on three-dimensional (3D) images of the lungs using non-enhanced computed tomography (CT). This study aimed to investigate the accuracy of 3D images of the lungs using non-enhanced CT. Methods: The study included 10 consecutive cases for each lung lobe, totalling 50 cases between March and December 2022. The patients had both non-enhanced and contrast-enhanced CT taken within 2 months before surgery. A 3D image analysis system (SYNAPSE VINCENT) was used to obtain 3D images of the pulmonary artery (PA), pulmonary vein (PV), and bronchus (Br). The system automatically generated 3D images based on both non-enhanced and contrast-enhanced CTs, which were then compared with each other and also with actual surgical findings. Results: The coincidence rate of PA, PV, and Br between 3D images based on non-enhanced CT and enhanced CT was 70% for the right lung and 65% for the left lung. The coincidence rate of PA, PV, and Br between 3D images based on non-enhanced CT and actual surgical findings was 100% for the right middle, right lower, and left lower lobes, but 50% for the right upper lobe and 60% for the left upper lobe. Conclusions: The 3D images of the lungs based on non-enhanced CT showed that the right middle lobe and both lower lobes were correctly depicted. The right and left upper lobes were poorly visualized using non-enhanced CT, while the right upper lobe was poorly visualized using contrast-enhanced CT.

    DOI: 10.21037/jtd-24-1406

    Open Access

    Web of Science

    Scopus

    PubMed

  4. Robot-Assisted Complex Anatomical Segmentectomy Using Resection Process Map. Open Access

    Nakamura S, Nakao M, Okado S, Kadomatsu Y, Ueno H, Chen-Yoshikawa TF

    Annals of thoracic surgery short reports   Vol. 2 ( 4 ) page: 643 - 645   2024.12

     More details

  5. A case of peribronchiolar metaplasia of the lung appearing as a solid nodule on computed tomography Open Access

    Takada, Y; Nakamura, S; Imamura, Y; Okado, S; Nomata, Y; Watanabe, H; Kadomatsu, Y; Ueno, H; Kato, T; Mizuno, T; Kojima, I; Chen-Yoshikawa, TF

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 86 ( 4 ) page: 720 - 725   2024.11

     More details

    Language:English   Publisher:Nagoya Journal of Medical Science  

    Peribronchiolar metaplasia is an uncommon lesion characterized by fibrosis and bronchiolar epithelial cell proliferation along the peribronchiolar alveolar walls, primarily in response to bronchiolar and peribronchiolar injuries. Peribronchiolar metaplasia usually appears as ground glass nodules or sub-solid nodules on computed tomography. However, we present an exceptional case of peribronchiolar metaplasia that appeared as a solitary solid nodule on computed tomography. A 62-year-old woman with conjunctival icterus was diagnosed with ampullary cancer and nodal metastasis. A solid predominant nodule (0.7 cm maximum diameter) in the left lower lobe was identified on computed tomography, requiring accurate differentiation between primary lung cancer and pulmonary metastasis. Due to the location, histological confirmation via transbronchial biopsy was not feasible. Hence, the patient underwent surgery for both diagnosis and treatment. The pathological findings revealed the growth of columnar epithelium containing ciliated cells replacing alveolar epithelium in the bronchioloalveolar wall with no malignant component. The final pathological diagnosis of the lesion was peribronchiolar metaplasia. This unique case highlights an atypical presentation of peribronchiolar metaplasia as a solitary solid nodule on computed tomography. Recognizing that peribronchiolar metaplasia can also manifest as solid nodules, as illustrated in our current case, is essential.

    DOI: 10.18999/nagjms.86.4.720

    Open Access

    Web of Science

    Scopus

    PubMed

▼display all

MISC 1

  1. Immunosuppressive treatment for myasthenia gravis crises improve the taste disorder in patients with thymoma: two case reports.

    Fukumoto K, Ohara Y, Okado S, Watanabe H, Noritake O, Nakanishi K, Kadomatsu Y, Ueno H, Kato T, Nakamura S, Chen-Yoshikawa TF

    Mediastinum (Hong Kong, China)   Vol. 7   page: 40   2023

     More details

    Language:English   Publisher:Mediastinum  

    Background: Taste disorders in patients with thymoma accompanied by myasthenia gravis (MG) is rare. Case Description: The first case was a male in his 50s who underwent surgery for Masaoka stage III type B3 thymoma. He experienced a loss of taste before surgery, which showed no improvement after surgery. Due to a MG crisis 44 days after surgery, the patient underwent intensive treatment with mechanical ventilation, steroid pulse therapy, and intravenous immunoglobulin (IVIG) therapy. The patient recovered taste when he started oral food intake after the treatment for the MG crisis (about 3 months after surgery). Despite the recovery of taste after steroid pulse therapy and IVIG therapy, taste disorder gradually worsened about 1 year and 9 months after surgery, resulting in an almost complete loss of sweet taste 2 years after surgery. The second case was a male in his 60s who underwent surgery for Masaoka stage II type B1 thymoma. He experienced loss of taste before surgery, which showed no improvement after surgery. Five years and two months after surgery, the patient was diagnosed with a MG crisis and underwent steroid pulse therapy. Along with improvements in MG symptoms, taste disorders gradually improved. After 6 years and 10 months of surgery, the patient is still alive without MG symptoms (only pyridostigmine, 180 mg/body/day), taste disorder, and thymoma recurrence. Conclusions: The autoimmune mechanism may contribute to taste disorders in patients with thymoma, which can be recovered by immunosuppressive treatment in our cases.

    DOI: 10.21037/med-23-8

    Scopus

    PubMed

Presentations 4

  1. Intraoperative and Postoperative air leak of RATS and VATS

    2022.10.6 

     More details

    Event date: 2022.10

    Country:Japan  

  2. ICGによる肺区域間同定法を利用した肺区域切除の検討

    上野陽史

    第5回日本蛍光ガイド手術研究会  2022.9.17 

     More details

    Event date: 2022.9

    Country:Japan  

  3. 【アプローチ別の術中および術後肺瘻発生頻度の比較】 -RATS vs VATS-

    上野陽史

    第122回日本外科学会定期学術集会  2022.4.15 

     More details

    Event date: 2022.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  4. TBLB後の気道出血による右気管支閉塞に対し緊急手術にて救命した肺癌の1例

    Harushi ueno

    中部肺癌学会  2021.2.6  日本肺癌学会

     More details

    Event date: 2021.2

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. Creation of intraoperative marker-less marking and novel surgical guide following variable lungs by deaeration and surgical procedure and d

    Grant number:24K02534  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Coinvestigator(s)